JP2022520803A5 - - Google Patents
Info
- Publication number
- JP2022520803A5 JP2022520803A5 JP2021547189A JP2021547189A JP2022520803A5 JP 2022520803 A5 JP2022520803 A5 JP 2022520803A5 JP 2021547189 A JP2021547189 A JP 2021547189A JP 2021547189 A JP2021547189 A JP 2021547189A JP 2022520803 A5 JP2022520803 A5 JP 2022520803A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- dna
- nucleic acid
- itr
- rep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024064717A JP2024083567A (ja) | 2019-02-15 | 2024-04-12 | 閉端DNA(ceDNA)の産生におけるREPタンパク質活性の調節 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962806076P | 2019-02-15 | 2019-02-15 | |
| US62/806,076 | 2019-02-15 | ||
| PCT/US2020/018332 WO2020168222A1 (en) | 2019-02-15 | 2020-02-14 | Modulation of rep protein activity in closed-ended dna (cedna) production |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024064717A Division JP2024083567A (ja) | 2019-02-15 | 2024-04-12 | 閉端DNA(ceDNA)の産生におけるREPタンパク質活性の調節 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022520803A JP2022520803A (ja) | 2022-04-01 |
| JP2022520803A5 true JP2022520803A5 (cg-RX-API-DMAC7.html) | 2023-02-22 |
| JP7644014B2 JP7644014B2 (ja) | 2025-03-11 |
Family
ID=72045641
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547189A Active JP7644014B2 (ja) | 2019-02-15 | 2020-02-14 | 閉端DNA(ceDNA)の産生におけるREPタンパク質活性の調節 |
| JP2024064717A Pending JP2024083567A (ja) | 2019-02-15 | 2024-04-12 | 閉端DNA(ceDNA)の産生におけるREPタンパク質活性の調節 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024064717A Pending JP2024083567A (ja) | 2019-02-15 | 2024-04-12 | 閉端DNA(ceDNA)の産生におけるREPタンパク質活性の調節 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220127625A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3924491A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7644014B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210127935A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113454232B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020221312A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3129321A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL285415A (cg-RX-API-DMAC7.html) |
| MA (1) | MA54958A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202106491VA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020168222A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020001593A (es) | 2017-08-09 | 2020-07-13 | Bioverativ Therapeutics Inc | Moleculas de acido nucleico y usos de las mismas. |
| JP7602454B2 (ja) | 2018-08-09 | 2024-12-18 | バイオベラティブ セラピューティクス インコーポレイテッド | 核酸分子及び非ウイルス遺伝子治療のためのそれらの使用 |
| PE20220233A1 (es) * | 2019-06-10 | 2022-02-07 | Homology Medicines Inc | Composiciones de virus adenoasociados para la transferencia del gen de arsa y metodos de uso de las mismas |
| MX2023001109A (es) | 2020-07-27 | 2023-04-24 | Anjarium Biosciences Ag | Composiciones de moleculas de adn, metodos para elaborar las mismas, y metodos de usos de las mismas. |
| MX2023003019A (es) * | 2020-09-16 | 2023-05-08 | Generation Bio Co | Vectores de adn de extremo cerrado y usos de estos para expresar fenilalanina hidroxilasa (pah). |
| US20240091382A1 (en) * | 2020-12-23 | 2024-03-21 | Vivet Therapeutics | Minimal bile acid inducible promoters for gene therapy |
| TW202302858A (zh) * | 2021-03-16 | 2023-01-16 | 威斯康辛校友研究基金會 | 治療糖尿病之胰島素基因療法 |
| WO2023028440A2 (en) * | 2021-08-23 | 2023-03-02 | Bioverativ Therapeutics Inc. | Baculovirus expression system |
| CN114703203B (zh) * | 2022-02-11 | 2024-08-06 | 上海渤因生物科技有限公司 | 杆状病毒载体及其用途 |
| KR102737146B1 (ko) * | 2023-07-10 | 2024-12-09 | 대한민국 | 신규 발현 벡터 및 이의 용도 |
| CN122341729A (zh) * | 2023-11-30 | 2026-07-03 | 赛诺菲 | 末端封闭的dna分子的纯化 |
| US12509711B1 (en) * | 2024-08-09 | 2025-12-30 | Martin Williams | System and process for in vivo manufacturing nanostructure-ended double-stranded covalently-closed linear DNA, the resulting molecules and their uses |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2596292C (en) * | 1997-03-21 | 2012-05-22 | Enzo Therapeutics, Inc. | Vectors and viral vectors, and packaging cell lines for propagating same |
| CN1183257C (zh) * | 1999-10-29 | 2005-01-05 | 宝生物工程株式会社 | 基因转移的方法 |
| WO2007148971A2 (en) * | 2006-06-21 | 2007-12-27 | Amsterdam Molecular Therapeutics B.V. | Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells |
| EP2545165B1 (en) * | 2010-03-11 | 2020-07-29 | uniQure IP B.V. | Mutated rep encoding sequences for use in aav production |
| EP2500434A1 (en) * | 2011-03-12 | 2012-09-19 | Association Institut de Myologie | Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery |
| WO2015137802A1 (en) * | 2014-03-10 | 2015-09-17 | Uniqure Ip B.V. | Further improved aav vectors produced in insect cells |
| IL261524B2 (en) * | 2016-03-03 | 2023-10-01 | Univ Massachusetts | End-capped linear double-stranded DNA for non-viral gene transfer |
| MX2020001593A (es) * | 2017-08-09 | 2020-07-13 | Bioverativ Therapeutics Inc | Moleculas de acido nucleico y usos de las mismas. |
-
2020
- 2020-02-14 CA CA3129321A patent/CA3129321A1/en active Pending
- 2020-02-14 EP EP20756257.0A patent/EP3924491A4/en not_active Withdrawn
- 2020-02-14 WO PCT/US2020/018332 patent/WO2020168222A1/en not_active Ceased
- 2020-02-14 US US17/430,341 patent/US20220127625A1/en active Pending
- 2020-02-14 MA MA054958A patent/MA54958A/fr unknown
- 2020-02-14 JP JP2021547189A patent/JP7644014B2/ja active Active
- 2020-02-14 CN CN202080014548.5A patent/CN113454232B/zh active Active
- 2020-02-14 KR KR1020217025576A patent/KR20210127935A/ko active Pending
- 2020-02-14 AU AU2020221312A patent/AU2020221312A1/en not_active Abandoned
- 2020-02-14 SG SG11202106491VA patent/SG11202106491VA/en unknown
-
2021
- 2021-08-05 IL IL285415A patent/IL285415A/en unknown
-
2024
- 2024-04-12 JP JP2024064717A patent/JP2024083567A/ja active Pending